Similar articles for PMID: 22990266

Year	Number of Results
1997	1
1998	1
1999	1
2000	2
2003	4
2004	2
2005	2
2006	2
2007	4
2008	4
2009	7
2010	9
2011	14
2012	11
2013	7
2014	9
2015	11
2016	3
2017	3
2018	5
2019	1
2020	2
2021	4
2022	1
2023	1
2024	0

1

FDA approval of obesity drugs: a difference in risk-benefit perceptions.

Morrato EH, Allison DB. Morrato EH, et al. JAMA. 2012 Sep 19;308(11):1097-8. doi: 10.1001/jama.2012.10007. JAMA. 2012. PMID: 22990266 Free PMC article. No abstract available.

2

Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States.

Aggarwal R, Vaduganathan M, Chiu N, Bhatt DL. Aggarwal R, et al. Prog Cardiovasc Dis. 2021 Sep-Oct;68:97-98. doi: 10.1016/j.pcad.2021.09.007. Epub 2021 Sep 21. Prog Cardiovasc Dis. 2021. PMID: 34560122 No abstract available.

3

Molecule of the month. The 'skinny' on CB1 antagonists/inverse agonists: controversial obesity drugs will not go to FDA for approval.

Lindsley CW. Lindsley CW. Curr Top Med Chem. 2008;8(17):1553. doi: 10.2174/156802608786413500. Curr Top Med Chem. 2008. PMID: 19097323 No abstract available.

4

Comparison table: some FDA-approved drugs for weight management.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Jun 4;60(1548):e98-e100. Med Lett Drugs Ther. 2018. PMID: 29913464 No abstract available.

5

Anti-obesity drugs: to be or not to be?

Dvorak RV, Sharma AM, Astrup A. Dvorak RV, et al. Obes Rev. 2010 Dec;11(12):833-4. doi: 10.1111/j.1467-789X.2010.00828.x. Epub 2010 Nov 3. Obes Rev. 2010. PMID: 21054758 No abstract available.

6

Lorcaserin for weight loss: insights into US Food and Drug Administration approval.

Miller LE. Miller LE. J Acad Nutr Diet. 2013 Jan;113(1):25-30. doi: 10.1016/j.jand.2012.08.028. J Acad Nutr Diet. 2013. PMID: 23260720 No abstract available.

7

Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.

Krentz AJ, Fujioka K, Hompesch M. Krentz AJ, et al. Diabetes Obes Metab. 2016 Jun;18(6):558-70. doi: 10.1111/dom.12657. Diabetes Obes Metab. 2016. PMID: 26936802 Review.

8

Drug management of obesity--efficacy versus safety.

Astrup A. Astrup A. N Engl J Med. 2010 Jul 15;363(3):288-90. doi: 10.1056/NEJMe1004076. N Engl J Med. 2010. PMID: 20647205 No abstract available.

9

Fat pill for teens. Xenical may have the FDA's blessing, but is it a good idea?

Gupta S. Gupta S. Time. 2003 Dec 29-2004 Jan 5;162(26):162. Time. 2003. PMID: 14722944 No abstract available.

10

The FDA's assessment of two drugs for chronic weight management.

Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosebraugh C. Colman E, et al. N Engl J Med. 2012 Oct 25;367(17):1577-9. doi: 10.1056/NEJMp1211277. Epub 2012 Oct 10. N Engl J Med. 2012. PMID: 23050510 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year